Vertex Pharmaceuticals | VRTX - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 4.88 4.80 Nov/09
FY2026Q2 Jun/2026 4.72 4.52 Aug/03
FY2026Q1 Mar/2026 4.47 4.43 4.06 May/04
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03




Eps Alterar Data
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
Arrowhead Research USD -0.93 1.15 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Incyte USD 1.81 0.01 2026-03
Insmed USD -0.76 0.78 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
J&J USD 2.9 0.2 2026-06
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 1.99 0.04 2026-03
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03